| Product Code: ETC7639496 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Rivaroxaban Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Rivaroxaban Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Rivaroxaban Market - Industry Life Cycle |
3.4 Ireland Rivaroxaban Market - Porter's Five Forces |
3.5 Ireland Rivaroxaban Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Ireland Rivaroxaban Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Rivaroxaban Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Ireland |
4.2.2 Growing awareness about the benefits of using rivaroxaban for stroke prevention |
4.2.3 Favorable government initiatives promoting the use of anticoagulants |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval process for new medications |
4.3.2 Competition from other anticoagulant drugs in the market |
4.3.3 Concerns about potential side effects and safety of rivaroxaban |
5 Ireland Rivaroxaban Market Trends |
6 Ireland Rivaroxaban Market, By Types |
6.1 Ireland Rivaroxaban Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Ireland Rivaroxaban Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Ireland Rivaroxaban Market Revenues & Volume, By Acute coronary syndrome, 2021- 2031F |
6.1.4 Ireland Rivaroxaban Market Revenues & Volume, By Pulmonary embolism, 2021- 2031F |
6.1.5 Ireland Rivaroxaban Market Revenues & Volume, By Venous thromboembolism, 2021- 2031F |
6.1.6 Ireland Rivaroxaban Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Rivaroxaban Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Ireland Rivaroxaban Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Ireland Rivaroxaban Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 Ireland Rivaroxaban Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Rivaroxaban Market Import-Export Trade Statistics |
7.1 Ireland Rivaroxaban Market Export to Major Countries |
7.2 Ireland Rivaroxaban Market Imports from Major Countries |
8 Ireland Rivaroxaban Market Key Performance Indicators |
8.1 Patient adherence rate to rivaroxaban treatment |
8.2 Number of healthcare providers prescribing rivaroxaban |
8.3 Frequency of educational campaigns on stroke prevention and anticoagulant therapy in Ireland |
9 Ireland Rivaroxaban Market - Opportunity Assessment |
9.1 Ireland Rivaroxaban Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Ireland Rivaroxaban Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Rivaroxaban Market - Competitive Landscape |
10.1 Ireland Rivaroxaban Market Revenue Share, By Companies, 2024 |
10.2 Ireland Rivaroxaban Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here